CAS: 691852-58-1
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | 5-Cyclopropyl-2-(4-fluorophenyl)-6-[(2-hydroxyethyl)(methylsulfonyl)amino]-N-methyl-3-benzofurancarboxamide REF: IN-DA00FC0LCAS: 691852-58-1 | 95% | To inquire | Mon 05 May 25 |
 | Nesbuvir REF: 54-BUP09100CAS: 691852-58-1 | ≥98% | 791.00 €~2,765.00 € | Tue 06 May 25 |
 | Nesbuvir REF: TM-TQ0090CAS: 691852-58-1 | 98.72% | 96.00 €~2,043.00 € | Mon 07 Jul 25 |
 | HCV 796 REF: 3D-FH103513CAS: 691852-58-1 | Min. 95% | - - - | Discontinued product |
![5-Cyclopropyl-2-(4-fluorophenyl)-6-[(2-hydroxyethyl)(methylsulfonyl)amino]-N-methyl-3-benzofuranca…](https://static.cymitquimica.com/products/IN/thumb/DA00FC0L.jpg)
5-Cyclopropyl-2-(4-fluorophenyl)-6-[(2-hydroxyethyl)(methylsulfonyl)amino]-N-methyl-3-benzofurancarboxamide
CAS:691852-58-1
Formula:
C22H23FN2O5S
Purity:
95%
Color and Shape:
Solid
Molecular weight:
446.4918231999999
Ref: IN-DA00FC0L
| 1mg | 193.00 € | ||
| 5mg | To inquire | ||
| 10mg | To inquire |
Estimated delivery in United States, on Monday 5 May 2025
Ref: 54-BUP09100
| 25mg | 791.00 € | ||
| 50mg | 1,141.00 € | ||
| 100mg | 1,377.00 € | ||
| 500mg | 2,765.00 € |
Estimated delivery in United States, on Tuesday 6 May 2025
Nesbuvir
CAS:691852-58-1
Nesbuvir: HCV NS5B polymerase inhibitor, IC50 9 nM against HCV 1b replicon in liver cancer …
Formula:
C22H23FN2O5S
Purity:
98.72%
Color and Shape:
Solid
Molecular weight:
446.49
Ref: TM-TQ0090
| 1mg | 96.00 € | ||
| 5mg | 227.00 € | ||
| 10mg | 305.00 € | ||
| 25mg | 530.00 € | ||
| 50mg | 777.00 € | ||
| 100mg | 1,017.00 € | ||
| 500mg | 2,043.00 € | ||
| 1mL*10mM (DMSO) | 250.00 € |
Estimated delivery in United States, on Monday 7 Jul 2025
HCV 796
CAS:691852-58-1
HCV 796 is a toll-like receptor modulator that can be used to treat HIV. It …
Formula:
C22H23FN2O5S
Purity:
Min. 95%
Molecular weight:
446.49 g/mol
Ref: 3D-FH103513
| 1mg | Discontinued | Request information | |
| 5mg | Discontinued | Request information | |
| 10mg | Discontinued | Request information |
